Search Result For: tirzepatide
Date: 2025/04/07 - 23:32
Amy Schumer Says Mounjaro Improved Perimenopause Symptoms, Sex Drive
Amy Schumer shared she quit Wegovy due to side effects like nausea but was "having a really good experience" with Mounjaro, including improved perimenopause symptoms and sex drive. Side effects with different GLP-1 drugs may vary from person to person.
Date: 2025/04/02 - 23:32
Compounded GLP-1s Helped Them Lose Weight, But New FDA Rule Could Block Access
The FDA's new rule restricting the sale of compounded semaglutide could make it more difficult for some people to obtain affordable weight loss medications. Here, two people who've relied on compounded GLP-1 drugs share their stories.
Date: 2025/04/02 - 23:00
Compounded GLP-1s Helped Them Lose Weight, But New FDA Rule Could Block Access
The FDA's new rule restricting the sale of compounded semaglutide could make it more difficult for some people to obtain affordable weight loss medications. Here, two people who've relied on compounded GLP-1 drugs share their stories.
Date: 2025/03/20 - 00:00
Compounding Pharmacies to Stop Making Ozempic, Zepound Knockoffs: What to Know
The FDA ordered compounding pharmacies to stop making copycat versions of weight loss drugs like Ozempic and Zepbound now that the GLP-1 drug shortage has ended. People who rely on compounded GLP-1s say they may not be able to afford brand-name versions, which are often not covered by insurance.
Date: 2025/03/17 - 15:01
Mounjaro can boost weight loss in people without diabetes
People without diabetes can lose up to 13% of their starting weight in 6 months using tirzepatide (Mounjaro) as an off-label treatment, according to a new study funded by pharmaceutical company Eli Lilly.
Date: 2025/02/10 - 21:00
Review links 3 potentially-blinding eye conditions to GLP-1 drugs like Ozempic
A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — experienced vision issues, including three potentially blinding eye conditions.
Date: 2024/12/06 - 00:00
Zepbound Leads to More Weight Loss Than Wegovy in Head-to-Head Clinical Trial
Drug manufacturer Eli Lilly says their drug Zepbound is more effective than Wegovy for long-term weight loss. Results from a clinical trial show 20% of participants who took Zepbound achieved significant weight loss compared to nearly 14% of participants who took Wegovy.